| Meghan Leigh Jolley, AUD | |
|
1005 N Glebe Rd Ste 500, Arlington, VA 22201-5702 | |
| (703) 644-7800 | |
| Not Available |
| Full Name | Meghan Leigh Jolley |
|---|---|
| Gender | Female |
| Speciality | Audiologist |
| Location | 1005 N Glebe Rd Ste 500, Arlington, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134909096 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 2201001644 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Meghan Leigh Jolley, AUD 4531 Arendale Sq, Alexandria, VA 22309-1217 Ph: (772) 240-9379 | Meghan Leigh Jolley, AUD 1005 N Glebe Rd Ste 500, Arlington, VA 22201-5702 Ph: (703) 644-7800 |
News Archive
Pfizer Inc. announced today that the European Commission has granted conditional marketing authorization for BOSULIF (bosutinib) in the European Union for the treatment of adult patients with chronic phase, accelerated phase and blast phase Philadelphia chromosome positive chronic myelogenous leukemia previously treated with one or more tyrosine kinase inhibitor(s) and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment options.
Family members are often the ones who administer naloxone during an opioid overdose and should be considered as part of the larger response to help curb fatal overdoses.
People with chronic kidney disease have a higher risk for heart disease and heart-disease death. Now, for the first time in humans, research led by Navkaranbir Bajaj, M.D., of the University of Alabama at Birmingham, has identified a pathological change that appears to link kidney disease to progressive heart disease.
Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that the United States Food and Drug Administration informed CTI that due to severe weather conditions in the Washington, D.C. area, the FDA is postponing the Oncologic Drugs Advisory Committee ("ODAC") meeting that was to be held on Wednesday, February 10, 2010 to discuss the pixantrone New Drug Application ("NDA"). The FDA indicated that it intends to reschedule the meeting as soon as the FDA can determine a schedule that will allow them to reconvene the advisory panel.
Women who put on weight as they approach middle-age could reduce their chances of enjoying a healthy old age by up to 80%, according to research from the University of Warwick.
› Verified 3 days ago
Advanced Hearing Health Care Plc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 611 S Carlin Springs Rd, #106, Arlington, VA 22204 Phone: 703-933-2001 Fax: 703-933-2007 | |
Dr. Colville William Heskey, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1635 N George Mason Dr, Suite 250, Arlington, VA 22205 Phone: 703-524-1212 Fax: 703-524-4595 | |
Dr. Ashley Kyra Tilahun, AU.D., CCC-A, FAAA Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1635 N George Mason Dr, Suite 250, Arlington, VA 22205 Phone: 703-524-1212 Fax: 703-524-1212 | |
Michelle Kim, M. CL. SC. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 611 S Carlin Springs Rd, Suite 106, Arlington, VA 22204 Phone: 703-933-2001 Fax: 703-933-2007 | |
Dr. Courtney M Little, AU.D Audiologist Medicare: Accepting Medicare Assignments Practice Location: 611 S Carlin Springs Rd Ste 106, Arlington, VA 22204 Phone: 703-933-2001 | |
Dr. Christine Brown Wright, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 4714 30th Street South, Arlington, VA 22206 Phone: 423-273-8071 |